Doliver Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-400
Closed -$2K 190
2020
Q1
$2K Buy
+400
New +$56.8K ﹤0.01% 167

Other funds holding JNJ

Doliver Advisors's JNJ Position: Q2 2026 in Review

Doliver Advisors reduced its Johnson & Johnson (JNJ) stake by 0.77% in Q2 2026, selling an estimated $18.4K and leaving 10,159 shares worth $2.58M. The position accounts for 0.58% of the portfolio, ranked #25.

Doliver Advisors first reported a position in JNJ in Q2 2017 and has held it in 37 quarters since. The position peaked at $2.67M in Q2 2023. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Doliver Advisors held 10,159 shares of Johnson & Johnson worth $2.58M as of Q2 2026.
  • Doliver Advisors sold 79 Johnson & Johnson shares in Q2 2026, an estimated $18.4K.
  • Johnson & Johnson made up 0.58% of Doliver Advisors's portfolio in Q2 2026, its #25 holding.
  • Doliver Advisors first reported a position in Johnson & Johnson in Q2 2017 and has held it in 37 quarters since.
  • Doliver Advisors's Johnson & Johnson position peaked at $2.67M in Q2 2023.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Doliver Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.